| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14 | 545 | 5 | - | - | - | 564 |
| - | - | - | - | - | 1 | - | - | - | - | 1 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 2 |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 179 |
| 409 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 564 | 74.6% | -9.14 | 1 | 0.2% |
| SLP(L) | 108 | 14.3% | 1.24 | 255 | 62.2% |
| PLP(L) | 49 | 6.5% | 0.43 | 66 | 16.1% |
| SCL(L) | 7 | 0.9% | 3.00 | 56 | 13.7% |
| LH(L) | 4 | 0.5% | 2.95 | 31 | 7.6% |
| Optic-unspecified(L) | 11 | 1.5% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 5 | 0.7% | -inf | 0 | 0.0% |
| SPS(L) | 4 | 0.5% | -inf | 0 | 0.0% |
| AME(L) | 2 | 0.3% | -inf | 0 | 0.0% |
| ICL(L) | 2 | 0.3% | -inf | 0 | 0.0% |
| WED(L) | 0 | 0.0% | inf | 1 | 0.2% |
| upstream partner | # | NT | conns MeVP35 | % In | CV |
|---|---|---|---|---|---|
| MeTu1 (L) | 21 | ACh | 140 | 20.2% | 0.5 |
| MeVPMe5 (R) | 6 | Glu | 64 | 9.2% | 1.0 |
| Cm3 (L) | 21 | GABA | 63 | 9.1% | 0.7 |
| MeVP6 (L) | 9 | Glu | 38 | 5.5% | 0.5 |
| MeVP10 (L) | 17 | ACh | 37 | 5.3% | 0.9 |
| MeVC8 (R) | 1 | ACh | 27 | 3.9% | 0.0 |
| Cm34 (L) | 1 | Glu | 24 | 3.5% | 0.0 |
| Mi10 (L) | 7 | ACh | 16 | 2.3% | 0.6 |
| MeLo3b (L) | 4 | ACh | 15 | 2.2% | 0.3 |
| MeTu3b (L) | 7 | ACh | 15 | 2.2% | 0.5 |
| Dm2 (L) | 11 | ACh | 14 | 2.0% | 0.3 |
| Cm4 (L) | 5 | Glu | 11 | 1.6% | 0.4 |
| LoVP64 (L) | 1 | Glu | 10 | 1.4% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 10 | 1.4% | 0.0 |
| Cm9 (L) | 4 | Glu | 10 | 1.4% | 0.6 |
| LoVP66 (L) | 1 | ACh | 9 | 1.3% | 0.0 |
| LoVP10 (L) | 3 | ACh | 9 | 1.3% | 0.3 |
| MeVC11 (R) | 1 | ACh | 8 | 1.2% | 0.0 |
| CB2685 (L) | 4 | ACh | 8 | 1.2% | 0.6 |
| Cm12 (L) | 6 | GABA | 8 | 1.2% | 0.4 |
| MeVP45 (L) | 1 | ACh | 7 | 1.0% | 0.0 |
| MeTu4d (L) | 3 | ACh | 7 | 1.0% | 0.5 |
| MeTu4c (L) | 4 | ACh | 7 | 1.0% | 0.5 |
| Tm5c (L) | 6 | Glu | 7 | 1.0% | 0.3 |
| MeVP12 (L) | 3 | ACh | 5 | 0.7% | 0.6 |
| Cm2 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| LoVP63 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| MeVC7a (R) | 1 | ACh | 4 | 0.6% | 0.0 |
| CB4152 (L) | 2 | ACh | 4 | 0.6% | 0.5 |
| Tm37 (L) | 3 | Glu | 4 | 0.6% | 0.4 |
| Tm34 (L) | 3 | Glu | 4 | 0.6% | 0.4 |
| LHAV3e3_a (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| Cm1 (L) | 2 | ACh | 3 | 0.4% | 0.3 |
| SLP361 (L) | 2 | ACh | 3 | 0.4% | 0.3 |
| Cm21 (L) | 2 | GABA | 3 | 0.4% | 0.3 |
| MeTu4a (L) | 3 | ACh | 3 | 0.4% | 0.0 |
| LHPV5j1 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP435 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP221 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm14 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| CB2555 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| MeLo4 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm6 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| Tm31 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| CL255 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm28 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP075 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CB0670 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL317 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| MeVPMe7 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| MeVC20 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 2 | 0.3% | 0.0 |
| Cm5 (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| Cm8 (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| LoVP85 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB4023 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ME_unclear (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LC36 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm16 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPLo2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP064_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP223 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu3c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV1c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP069 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP252 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab-p (L) | 1 | DA | 1 | 0.1% | 0.0 |
| TmY10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0142 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP395 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3541 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm22 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| PLP087 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LoVP17 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP086 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP372 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1059 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL086_c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL359 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP224 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6o1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| AOTU065 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe30 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| HBeyelet (L) | 1 | HA | 1 | 0.1% | 0.0 |
| LPT114 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP33 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC5 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PS196_b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP29 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| mALD1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns MeVP35 | % Out | CV |
|---|---|---|---|---|---|
| SLP435 (L) | 1 | Glu | 104 | 15.6% | 0.0 |
| SMP235 (L) | 1 | Glu | 68 | 10.2% | 0.0 |
| SLP223 (L) | 2 | ACh | 36 | 5.4% | 0.5 |
| CB1733 (L) | 2 | Glu | 35 | 5.3% | 0.4 |
| SLP207 (L) | 1 | GABA | 28 | 4.2% | 0.0 |
| CB2638 (L) | 3 | ACh | 26 | 3.9% | 0.9 |
| PLP065 (L) | 3 | ACh | 22 | 3.3% | 1.0 |
| SLP372 (L) | 2 | ACh | 22 | 3.3% | 0.1 |
| LHAV3n1 (L) | 3 | ACh | 20 | 3.0% | 0.4 |
| SLP224 (L) | 2 | ACh | 18 | 2.7% | 0.8 |
| CRZ01 (L) | 1 | unc | 16 | 2.4% | 0.0 |
| CB3541 (L) | 2 | ACh | 14 | 2.1% | 0.1 |
| MeVP45 (L) | 1 | ACh | 11 | 1.7% | 0.0 |
| CB3050 (L) | 3 | ACh | 11 | 1.7% | 0.8 |
| SLP344 (L) | 2 | Glu | 10 | 1.5% | 0.4 |
| SLP273 (L) | 1 | ACh | 9 | 1.4% | 0.0 |
| CB2269 (L) | 2 | Glu | 9 | 1.4% | 0.6 |
| SLP074 (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| CB1950 (L) | 1 | ACh | 7 | 1.1% | 0.0 |
| SLP088_a (L) | 3 | Glu | 7 | 1.1% | 0.5 |
| PLP064_b (L) | 2 | ACh | 7 | 1.1% | 0.1 |
| MeVC27 (L) | 3 | unc | 6 | 0.9% | 0.7 |
| CB2685 (L) | 3 | ACh | 6 | 0.9% | 0.4 |
| SMP044 (L) | 1 | Glu | 5 | 0.8% | 0.0 |
| CB1178 (L) | 1 | Glu | 5 | 0.8% | 0.0 |
| PLP066 (L) | 1 | ACh | 5 | 0.8% | 0.0 |
| PPL203 (L) | 1 | unc | 5 | 0.8% | 0.0 |
| SLP444 (L) | 2 | unc | 5 | 0.8% | 0.2 |
| MeVP10 (L) | 4 | ACh | 5 | 0.8% | 0.3 |
| ATL023 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| PPL204 (L) | 1 | DA | 4 | 0.6% | 0.0 |
| SLP462 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| CB3141 (L) | 2 | Glu | 4 | 0.6% | 0.0 |
| PLP131 (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| CRE108 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| SLP087 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| SMP171 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| SLP028 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| CL359 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| PS272 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVP40 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| CRZ02 (L) | 1 | unc | 3 | 0.5% | 0.0 |
| MeVP33 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| aMe17a (L) | 1 | unc | 3 | 0.5% | 0.0 |
| CB4119 (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| CB2302 (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| SMP411 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PLP064_a (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP548 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP528 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP412_b (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP002 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| SLP308 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SMP427 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP341_a (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP098 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SMP045 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP305 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP386 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB1467 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| PLP258 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV9b1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP221 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6c2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP595 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP358 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP134 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB2295 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3069 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP331 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP286 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP384 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVP81 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP337 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP412 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SIP032 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP10 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1337 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP361 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP402_b (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3252 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD1b1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP122_a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP036 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP119 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP251 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV10a1b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB2563 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| FB2J_b (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm14 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SLP360_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP062 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMP189 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP65 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL100 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP34 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP304 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| CB0510 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP067 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP069 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |